Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that ca...
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Those leading the charge have not only realized strong financial ...
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a...
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the ...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
iRhythm’s stock price has taken a beating over the past six months, shedding 37.6% of its value and falling to $114.01 per share. This may have investors won...
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
iRhythm Technologies (NASDAQ:IRTC) executives said the company is seeing continued business momentum after a favorable Medicare coverage update, a stronger-than-expected first quarter and progress on several product and margin initiatives.
Speaking at an investor event, Stephanie Zhadkevich, senior
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet...
iRhythm’s first quarter saw a mix of strong financial performance and a muted market response, as revenue and adjusted profits surpassed Wall Street expectat...
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 25.7% yea...
Medical technology company iRhythm Technologies (NASDAQ:IRTC) announced better-than-expected revenue in Q1 CY2026, with sales up 25.7% year on year to $199.4...
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be reporting results this Thursday after market hours. Here’s what you need to know. iRhyt...
What Happened? Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.4% in the afternoon session after the company announced posit...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl...
iRhythm has gotten torched over the last six months - since October 2025, its stock price has dropped 31.2% to $125.18 per share. This might have investors c...
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at iRhythm (NASDAQ:IRTC) and its...
RTW Investments loads up on iRhythm Holdings with 1.18M Shares Worth $210 million. iRhythm delivers wearable cardiac monitoring and analytics solutions to healthcare providers and at-risk patients.
A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures.
